Breast cancer in moroccan young women: a retrospective study

BMC Research Notes

Table 4 OS and EFS in patients35 years and younger with local breast cancer

	No. of patients	3-Year OS(%)	P	3-Year EFS(%)	P
Stage I-III	356	83.2	-	62.5	-
Tumor size
T1	48	89.3	0.76	75.9	0.32
T2	161	85.5		65
T3	71	79.5		56
T4	76	77.5		55.2
SBR grading
SBR I	14	100	0.20	67.5	0.45
SBR II	176	84.9		63.2
SBR III	137	78		58.8
ER
ER positive	179	94.4	0.001	75.8	0.001
ER negative	149	70.2		50.6
N stage
N0	107	79.4	0.32	59.8	0.20
N+	249	84.8		63.6
Surgery type
Radical mastectomy	265	82.3	0.17	61.9	0.059
Conserving surgery	80	87.7		70.4
Adjuvant radiotherapy
Yes	290	85.2	0.002	65.7	0.001
No	66	70.2		48.6
Adjuvant chemotherapy
No	45	65.4	0.04	44.7	0.001
Yes	311	85		64.9
Hormonotherapy
Yes	232	85.9	0.001	69.5	0.001
No	124	76.6		48
Stage
I	30	100	0.001	93	0.001
II	140	89.4		76.3
III	186	74.7		46.8

ER. estrogen receptors; N. lymph node; CI. confidence interval; OS. overall survival; EFS. event free survival.

ISSN: 1756-0500